$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
3 Dividend Stocks That Have Been Paying Investors Since the 1800s
09:00am, Wednesday, 29'th Mar 2023
Eli Lilly, ExxonMobil, and the Toronto-Dominion Bank are all solid companies. Impressively, all three have been paying dividends for over 100 years.
Is Eli Lilly or Bristol Myers Squibb the Better Value Stock to Buy Right Now?
10:15am, Tuesday, 28'th Mar 2023
Big pharma stocks ought to perform well in the current high interest rate environment. Eli Lilly and Bristol Myers Squibb have long been top value plays.
Novartis Surges As It Goes After Eli Lilly's Second Biggest Moneymaker
10:17am, Monday, 27'th Mar 2023
Novartis stock surged Monday after the company's treatment reduced the risk of relapse in patients with early-stage breast cancer. The post Novartis Surges As It Goes After Eli Lilly's Second Biggest
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:57am, Monday, 27'th Mar 2023
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
02:37pm, Friday, 24'th Mar 2023
Novo Nordisk stock popped Friday after higher doses of its popular drug, semaglutide, led to greater weight loss in diabetes patients. The post The Ozempic Obesity Battle Is Heating Up With Novo Scori
Will Eli Lilly Be a Trillion-Dollar Stock by 2030?
10:23am, Thursday, 23'rd Mar 2023
Eli Lilly didn't generate much growth last year, but its future looks promising. Mounjaro has the potential to be a game-changing product for the business.
1 Stock Down 9% in 2023 to Buy and Hold Forever
08:15am, Thursday, 23'rd Mar 2023
Eli Lilly is one of the biggest names in the diabetes drugs market. But the company's lineup and pipeline extend well beyond this area.
Eli Lilly: Best-Now Near-Term Price Gains Pharmaceuticals Stock
12:32am, Thursday, 23'rd Mar 2023
84% of shares held by 3370 “institutional” investors, with over 80% of its $315 Billion market capitalization traded in a year. Not a buy-to-hold because prior forecasts like today's 8-to-1 wins t
Alzheimer's Blood Test That Could Help Diagnose Disease Earlier Is Being Developed By Eli Lilly And Roche
09:09am, Wednesday, 22'nd Mar 2023
If approved, the test could streamline the diagnostic journey and help patients get earlier access to future Alzheimer's treatments, Roche said.
Eli Lilly Is Priced for Perfection in the Obesity Market
09:00am, Wednesday, 22'nd Mar 2023
The company has outperformed its pharma peers in recent years, but its valuation leaves little room for error.
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
04:13pm, Tuesday, 21'st Mar 2023
Stock market investors have been on a rollercoaster ride over the past year. The Federal Reserve continues to be hawkish in controlling inflation.
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
10:43am, Tuesday, 21'st Mar 2023
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
Beat the Dow Jones With This Unstoppable Dividend Stock
10:15am, Tuesday, 21'st Mar 2023
Eli Lilly possesses a deep product portfolio and pipeline. The company's rapid dividend growth should continue.
Sanofi becomes latest to cut insulin prices, joins Novo Nordisk, Eli Lilly
10:25am, Friday, 17'th Mar 2023
Yahoo Finance's Anjalee Khemlani joins the Live show to report that Sanofi has become the latest major drug company to slash insulin prices, capping the cost at $35.
Sanofi Cuts Insulin Prices Up To 78%—Following Eli Lilly And Novo Nordisk
05:45pm, Thursday, 16'th Mar 2023
The French company will cap the monthly cost of insulin at $35, after Novo Nordisk and Eli Lilly also announced major price cuts earlier this month.
Sign In
Buy LLY